https://journals.mlacwresearch.org/index.php/ijfas IJFAS (ISSN: 2278-1404) is a peer-reviewed open-access journal publishing original research in fundamental and applied biological sciences. mLAC en-US International Journal of Fundamental and Applied Sciences (IJFAS) 2278-1404 <blockquote data-start="293" data-end="849"> <p data-start="295" data-end="849"><strong data-start="295" data-end="316">License Statement</strong><br data-start="316" data-end="319" />This work is licensed under a <a class="" href="https://creativecommons.org/licenses/by/4.0/" target="_new" rel="noopener" data-start="349" data-end="463">Creative Commons Attribution 4.0 International License (CC BY 4.0)</a>.<br data-start="464" data-end="467" />Authors who publish with <strong>International Journal of Fundamental and Applied Sciences (IJFAS)</strong> retain copyright of their articles and grant the journal the right of first publication.<br data-start="638" data-end="641" />This license allows others to share, use, and build upon the work—commercially or non-commercially—<strong data-start="740" data-end="782">as long as appropriate credit is given</strong> to the original authors and source, and any changes are indicated.</p> </blockquote> <blockquote data-start="851" data-end="983"> <p data-start="853" data-end="983">The journal encourages open access and supports the free exchange of knowledge while ensuring proper attribution of original work.</p> </blockquote> https://journals.mlacwresearch.org/index.php/ijfas/article/view/280 <p>Micronutrient deficiencies (MND) impact approximately 2 billion individuals globally, contributing to significant morbidity and mortality. The National Family Health Survey-5 reveals that 57% of Indian women aged 15-49 are anaemic, with anaemia affecting 59% of adolescent girls and 30% of adolescent boys. A 2021 meta-analysis of 270 studies found vitamin D deficiency to be the most prevalent in India, affecting 61% of the population, followed by deficiencies in iron (54%), vitamin B12 (53%), folic acid (37%), and iodine (17%). This study aimed to evaluate the efficacy and safety of a 4.6 g daily dose of the Good Monk Nutrition Premix in enhancing gut health, energy levels, immune function, and addressing micronutrient deficiencies in healthy individuals aged 13–35 years. The study was conducted as a single-arm, open-label clinical trial over 120 days, with participants receiving Good Monk as an adjuvant to their regular diet. Primary outcomes included gut health, energy, growth, immunity, and micronutrient levels (Vitamin B12, Vitamin D, Iron) biomarkers such as Immunoglobulin G (IgG), C-reactive protein (CRP). Results indicated significant improvements in gut health, with reductions in gastrointestinal symptoms, enhanced energy levels (24.4% improvement in the 30-Second Chair Stand Test), and increased micronutrient levels. Micronutrient analysis revealed notable improvement of 65.4%, 26% and 30.8% in vitamin B12, Vitamin D and iron levels from baseline to the final visit at 120 days. Additionally, significant improvements in immunity were observed. The Nutrition Premix was well-tolerated, with no significant adverse events. These findings suggest that Good Monk nutrition premix may be an effective, safe addition to dietary practices to improve gut health, energy, immunity, and address micronutrient deficiencies.</p> Poorvi Athreya L. Sucharitha Amarpreet Singh Anand Shovan Ganguli Dheeraj Deep Copyright (c) 2025 Dheeraj Deep https://creativecommons.org/licenses/by/4.0 2025-09-30 2025-09-30 14 3 1 11 10.59415/ijfas.v14i3.280